FilingSEC EDGAR6-K
Purple Biotech Receives U.S. Notice of Allowance for CAPTN-3 Platform Patent
· SEC accepted
StagePatent Allowance
Filing content
The company received a Notice of Allowance from the USPTO for a patent covering tri-specific antibody constructs, strengthening the intellectual property protection for its CAPTN-3 platform.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…